PDK4-mediated metabolic reprogramming is a potential therapeutic target for neovascular age-related macular degeneration

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
Extent
1 Online-Ressource.
Language
Englisch

Bibliographic citation
PDK4-mediated metabolic reprogramming is a potential therapeutic target for neovascular age-related macular degeneration ; volume:15 ; number:8 ; day:9 ; month:8 ; year:2024 ; pages:1-10 ; date:8.2024
Cell death & disease ; 15, Heft 8 (9.8.2024), 1-10, 8.2024

Creator
Kim, Juhee
Jeon, Yujin
Son, Jinyoung
Pagire, Haushabhau S.
Pagire, Suvarna H.
Ahn, Jin Hee
Uemura, Akiyoshi
Lee, In-Kyu
Park, Sungmi
Park, Dong Ho
Contributor
SpringerLink (Online service)

DOI
10.1038/s41419-024-06968-0
URN
urn:nbn:de:101:1-2410291023529.561250246928
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
15.08.2025, 7:23 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Kim, Juhee
  • Jeon, Yujin
  • Son, Jinyoung
  • Pagire, Haushabhau S.
  • Pagire, Suvarna H.
  • Ahn, Jin Hee
  • Uemura, Akiyoshi
  • Lee, In-Kyu
  • Park, Sungmi
  • Park, Dong Ho
  • SpringerLink (Online service)

Other Objects (12)

Macular Hole Formation Following Intravitreal Aflibercept for Neovascular Age-Related Macular Degeneration

Macular Hole Formation Following Intravitreal Aflibercept for Neovascular Age-Related Macular Degeneration

Near-infrared reflectance imaging of neovascular age-related macular degeneration

Near-infrared reflectance imaging of neovascular age-related macular degeneration

Mineralocorticoid Antagonists as Adjuncts in Neovascular Age-Related Macular Degeneration

Mineralocorticoid Antagonists as Adjuncts in Neovascular Age-Related Macular Degeneration

Efficacy and safety of abicipar in neovascular age-related macular degeneration

Efficacy and safety of abicipar in neovascular age-related macular degeneration

Vision protection therapy for prevention of neovascular age-related macular degeneration

Vision protection therapy for prevention of neovascular age-related macular degeneration

Treatment of age-related neovascular macular degeneration: the patient’s perspective

Treatment of age-related neovascular macular degeneration: the patient’s perspective

Evolution of macular atrophy in eyes with neovascular age-related macular degeneration compared to fellow non-neovascular eyes

Evolution of macular atrophy in eyes with neovascular age-related macular degeneration compared to fellow non-neovascular eyes

Influence of new societal factors on neovascular age-related macular degeneration outcomes

Influence of new societal factors on neovascular age-related macular degeneration outcomes

Emerging therapeutic strategies for unmet need in neovascular age-related macular degeneration

Emerging therapeutic strategies for unmet need in neovascular age-related macular degeneration

Intravitreal Brolucizumab for Neovascular Age-Related Macular Degeneration in a Vitrectomized Eye

Intravitreal Brolucizumab for Neovascular Age-Related Macular Degeneration in a Vitrectomized Eye

Sub-retinal pigment epithelium tubules in non-neovascular age-related macular degeneration

Sub-retinal pigment epithelium tubules in non-neovascular age-related macular degeneration

Characterization of two-pore channel 2 in neovascular age-related macular degeneration

Characterization of two-pore channel 2 in neovascular age-related macular degeneration

Related objects